The largest database of trusted experimental protocols

Lentiviral hmagea2 shrna vectors

Manufactured by Merck Group

Lentiviral hMAGEA2 shRNA vectors are a type of laboratory equipment used in genetic research. They are designed to deliver short hairpin RNA (shRNA) targeting the human MAGEA2 gene into cells using a lentiviral delivery system. The primary function of these vectors is to enable the knockdown or silencing of the MAGEA2 gene expression in experimental settings, allowing researchers to study the effects of MAGEA2 gene modulation.

Automatically generated - may contain errors

2 protocols using lentiviral hmagea2 shrna vectors

1

Lentiviral-mediated hMAGEA2 Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lentiviral hMAGEA2 shRNA vectors (shMAGEA2 sequence: 5′-GATAATCGTCCTGGCC ATAAT-3′) for the knockdown of hMAGEA2 were purchased from Sigma. Oligonucleotides were cloned into the pLKO.1 lentiviral vector. HEK293T cells were co-transfected with pLKO.1-scramble or pLKO.1-shMAGEA2 and pMDLg/p RRE, pMD2.G, and pRSV-Rev using FuGENE HD transfection reagent (Promega). The MDA-MB-468 cells were infected with lentiviruses encoding shRNA using 8 μg/mL protamine sulfate (Sigma). After 48 h, cells were selected by puromycin (1 μg/ml) for 4 days, establishing a stable knockdown of hMAGEA2 in the MDA-MB-468 cell line.
+ Open protocol
+ Expand
2

Lentiviral Knockdown of hMAGEA2 in Melanoma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The lentiviral hMAGEA2 shRNA vectors (sh-hMAGEA2 sequence: 5′-GATAATCGTCCTGGCCATAAT-3′) for the knockdown of hMAGEA2 were purchased from Sigma. Oligonucleotides were cloned into the pLKO.1 lentiviral vector. HEK293T cells were co-transfected with pLKO.1-scramble or pLKO.1-shMAGEA2 and pMDLg/p RRE, pMD2.G, and pRSV-Rev using FuGENE HD transfection reagent (Promega). SK-MEL-5 and SK-MEL-28 cells were infected with lentiviruses encoding shRNA using 8 µg/ml protamine sulfate (Sigma). After 48 h, cells were selected by puromycin (1 µg/ml) for 4 days to establish a stable knockdown of hMAGEA2 in the SK-MEL-5 and SK-MEL-28 cell lines.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!